{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["SARS-CoV-2", "antiviral effects", "antiviral targets", "polyphenols"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "34830267", "DateCompleted": {"Year": "2021", "Month": "12", "Day": "03"}, "DateRevised": {"Year": "2024", "Month": "04", "Day": "04"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "11", "Day": "17"}], "Language": ["eng"], "ELocationID": ["12385", "10.3390/ijms222212385"], "Journal": {"ISSN": "1422-0067", "JournalIssue": {"Volume": "22", "Issue": "22", "PubDate": {"Year": "2021", "Month": "Nov", "Day": "17"}}, "Title": "International journal of molecular sciences", "ISOAbbreviation": "Int J Mol Sci"}, "ArticleTitle": "Molecular Mechanisms of Possible Action of Phenolic Compounds in COVID-19 Protection and Prevention.", "Abstract": {"AbstractText": ["The worldwide outbreak of COVID-19 was caused by a pathogenic virus called Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2). Therapies against SARS-CoV-2 target the virus or human cells or the immune system. However, therapies based on specific antibodies, such as vaccines and monoclonal antibodies, may become inefficient enough when the virus changes its antigenicity due to mutations. Polyphenols are the major class of bioactive compounds in nature, exerting diverse health effects based on their direct antioxidant activity and their effects in the modulation of intracellular signaling. There are currently numerous clinical trials investigating the effects of polyphenols in prophylaxis and the treatment of COVID-19, from symptomatic, via moderate and severe COVID-19 treatment, to anti-fibrotic treatment in discharged COVID-19 patients. Antiviral activities of polyphenols and their impact on immune system modulation could serve as a solid basis for developing polyphenol-based natural approaches for preventing and treating COVID-19."]}, "AuthorList": [{"Identifier": ["0000-0002-8691-2486"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute for the Application of Nuclear Energy, Department for Metabolism, University of Belgrade, Banatska 31b, 11080 Belgrade, Serbia."}], "LastName": "Gligorijevic", "ForeName": "Nikola", "Initials": "N"}, {"Identifier": ["0000-0003-3701-6017"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Center of Excellence for Molecular Food Sciences, Department of Biochemistry, Faculty of Chemistry, University of Belgrade, Studentski trg 12-16, 11000 Belgrade, Serbia."}], "LastName": "Radomirovic", "ForeName": "Mirjana", "Initials": "M"}, {"Identifier": ["0000-0003-2042-0056"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute for the Application of Nuclear Energy, Department for Metabolism, University of Belgrade, Banatska 31b, 11080 Belgrade, Serbia."}], "LastName": "Nedic", "ForeName": "Olgica", "Initials": "O"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Center of Excellence for Molecular Food Sciences, Department of Biochemistry, Faculty of Chemistry, University of Belgrade, Studentski trg 12-16, 11000 Belgrade, Serbia."}], "LastName": "Stojadinovic", "ForeName": "Marija", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Faculty of Bioscience Engineering, Ghent University, 9000 Ghent, Belgium."}, {"Identifier": [], "Affiliation": "Global Campus, Ghent University, Yeonsu-gu, Incheon 21985, Korea."}], "LastName": "Khulal", "ForeName": "Urmila", "Initials": "U"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Center of Excellence for Molecular Food Sciences, Department of Biochemistry, Faculty of Chemistry, University of Belgrade, Studentski trg 12-16, 11000 Belgrade, Serbia."}], "LastName": "Stanic-Vucinic", "ForeName": "Dragana", "Initials": "D"}, {"Identifier": ["0000-0003-2559-5234"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Center of Excellence for Molecular Food Sciences, Department of Biochemistry, Faculty of Chemistry, University of Belgrade, Studentski trg 12-16, 11000 Belgrade, Serbia."}, {"Identifier": [], "Affiliation": "Faculty of Bioscience Engineering, Ghent University, 9000 Ghent, Belgium."}, {"Identifier": [], "Affiliation": "Global Campus, Ghent University, Yeonsu-gu, Incheon 21985, Korea."}, {"Identifier": [], "Affiliation": "Serbian Academy of Sciences and Arts, Knez Mihailova 35, 11000 Belgrade, Serbia."}], "LastName": "Cirkovic Velickovic", "ForeName": "Tanja", "Initials": "T"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Int J Mol Sci", "NlmUniqueID": "101092791", "ISSNLinking": "1422-0067"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antiviral Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Polyphenols"}, {"RegistryNumber": "0", "NameOfSubstance": "Spike Glycoprotein, Coronavirus"}, {"RegistryNumber": "0", "NameOfSubstance": "spike protein, SARS-CoV-2"}, {"RegistryNumber": "EC 3.4.22.-", "NameOfSubstance": "3C-like proteinase, SARS-CoV-2"}, {"RegistryNumber": "EC 3.4.22.2", "NameOfSubstance": "Coronavirus Papain-Like Proteases"}, {"RegistryNumber": "EC 3.4.22.2", "NameOfSubstance": "papain-like protease, SARS-CoV-2"}, {"RegistryNumber": "EC 3.4.22.28", "NameOfSubstance": "Coronavirus 3C Proteases"}], "MeshHeadingList": [{"QualifierName": ["chemistry", "metabolism", "therapeutic use"], "DescriptorName": "Antiviral Agents"}, {"QualifierName": ["prevention & control", "virology"], "DescriptorName": "COVID-19"}, {"QualifierName": ["antagonists & inhibitors", "metabolism"], "DescriptorName": "Coronavirus 3C Proteases"}, {"QualifierName": ["antagonists & inhibitors", "metabolism"], "DescriptorName": "Coronavirus Papain-Like Proteases"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["chemistry", "metabolism"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["chemistry", "metabolism", "therapeutic use"], "DescriptorName": "Polyphenols"}, {"QualifierName": ["isolation & purification", "metabolism"], "DescriptorName": "SARS-CoV-2"}, {"QualifierName": ["antagonists & inhibitors", "metabolism"], "DescriptorName": "Spike Glycoprotein, Coronavirus"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Gupta A., Madhavan M.V., Sehgal K., Nair N., Mahajan S., Sehrawat T.S., Bikdeli B., Ahluwalia N., Ausiello J.C., Wan E.Y., et al. Extrapulmonary manifestations of COVID-19. Nat. Med. 2020;26:1017\u20131032. doi: 10.1038/s41591-020-0968-3.", "ArticleIdList": ["10.1038/s41591-020-0968-3", "32651579"]}, {"Citation": "Lai C.-C., Ko W.-C., Lee P.-I., Jean S.-S., Hsueh P.-R. Extra-respiratory manifestations of COVID-19. Int. J. Antimicrob. Agents. 2020;56:106024. doi: 10.1016/j.ijantimicag.2020.106024.", "ArticleIdList": ["10.1016/j.ijantimicag.2020.106024", "PMC7243791", "32450197"]}, {"Citation": "Zheng K.I., Feng G., Liu W., Targher G., Byrne C.D., Zheng M. Extrapulmonary complications of COVID-19: A multisystem disease? J. Med. Virol. 2021;93:323\u2013335. doi: 10.1002/jmv.26294.", "ArticleIdList": ["10.1002/jmv.26294", "PMC7405144", "32648973"]}, {"Citation": "Dong M., Zhang J., Ma X., Tan J., Chen L., Liu S., Xin Y., Zhuang L. ACE2, TMPRSS2 distribution and extrapulmonary organ injury in patients with COVID-19. Biomed. Pharmacother. 2020;131:110678. doi: 10.1016/j.biopha.2020.110678.", "ArticleIdList": ["10.1016/j.biopha.2020.110678", "PMC7444942", "32861070"]}, {"Citation": "Paraiso I.L., Revel J.S., Stevens J.F. Potential use of polyphenols in the battle against COVID-19. Curr. Opin. Food Sci. 2020;32:149\u2013155. doi: 10.1016/j.cofs.2020.08.004.", "ArticleIdList": ["10.1016/j.cofs.2020.08.004", "PMC7480644", "32923374"]}, {"Citation": "Annunziata G., Sanduzzi Zamparelli M., Santoro C., Ciampaglia R., Stornaiuolo M., Tenore G.C., Sanduzzi A., Novellino E. May polyphenols have a role against coronavirus infection? An overview of in vitro evidence. Front. Med. 2020;7:240. doi: 10.3389/fmed.2020.00240.", "ArticleIdList": ["10.3389/fmed.2020.00240", "PMC7243156", "32574331"]}, {"Citation": "Prasansuklab A., Theerasri A., Rangsinth P., Sillapachaiyaporn C., Chuchawankul S., Tencomnao T. Anti-COVID-19 drug candidates: A review on potential biological activities of natural products in the management of new coronavirus infection. J. Tradit. Complement. Med. 2021;11:144\u2013157. doi: 10.1016/j.jtcme.2020.12.001.", "ArticleIdList": ["10.1016/j.jtcme.2020.12.001", "PMC7833040", "33520683"]}, {"Citation": "Pamuru R.R., Ponneri N., Damu A.G., Vadde R. Targeting natural products for the treatment of COVID-19\u2014An updated review. Curr. Pharm. Des. 2020;26:5278\u20135285. doi: 10.2174/1381612826666200903122536.", "ArticleIdList": ["10.2174/1381612826666200903122536", "32881659"]}, {"Citation": "Omokhua-Uyi A.G., Van Staden J. Natural product remedies for COVID-19: A focus on safety. S. Afr. J. Bot. 2021;139:386\u2013398. doi: 10.1016/j.sajb.2021.03.012.", "ArticleIdList": ["10.1016/j.sajb.2021.03.012", "PMC7970016", "33753960"]}, {"Citation": "Huang J., Tao G., Liu J., Cai J., Huang Z., Chen J. Current prevention of COVID-19: Natural products and herbal medicine. Front. Pharmacol. 2020;11:588508. doi: 10.3389/fphar.2020.588508.", "ArticleIdList": ["10.3389/fphar.2020.588508", "PMC7597394", "33178026"]}, {"Citation": "Chakravarti R., Singh R., Ghosh A., Dey D., Sharma P., Velayutham R., Roy S., Ghosh D. A review on potential of natural products in the management of COVID-19. RSC Adv. 2021;11:16711\u201316735. doi: 10.1039/D1RA00644D.", "ArticleIdList": ["10.1039/D1RA00644D", "PMC9031656", "35479175"]}, {"Citation": "Quero J., M\u00e1rmol I., Cerrada E., Rodr\u00edguez-Yoldi M.J. Insight into the potential application of polyphenol-rich dietary intervention in degenerative disease management. Food Funct. 2020;11:2805\u20132825. doi: 10.1039/D0FO00216J.", "ArticleIdList": ["10.1039/D0FO00216J", "32134090"]}, {"Citation": "Serreli G., Deiana M. In vivo formed metabolites of polyphenols and their biological efficacy. Food Funct. 2019;10:6999\u20137021. doi: 10.1039/C9FO01733J.", "ArticleIdList": ["10.1039/C9FO01733J", "31659360"]}, {"Citation": "Dejani N.N., Elshabrawy H.A., da Silva Maia Bezerra Filho C., de Sousa D.P. Anticoronavirus and immunomodulatory phenolic compounds: Opportunities and pharmacotherapeutic perspectives. Biomolecules. 2021;11:1254. doi: 10.3390/biom11081254.", "ArticleIdList": ["10.3390/biom11081254", "PMC8394099", "34439920"]}, {"Citation": "del Carmen Villegas-Aguilar M., Fern\u00e1ndez-Ochoa \u00c1., de la Luz C\u00e1diz-Gurrea M., Pimentel-Moral S., Lozano-S\u00e1nchez J., Arr\u00e1ez-Rom\u00e1n D., Segura-Carretero A. Pleiotropic biological effects of dietary phenolic compounds and their metabolites on energy metabolism, inflammation and aging. Molecules. 2020;25:596. doi: 10.3390/molecules25030596.", "ArticleIdList": ["10.3390/molecules25030596", "PMC7037231", "32013273"]}, {"Citation": "Matacchione G., Gur\u0103u F., Baldoni S., Prattichizzo F., Silvestrini A., Giuliani A., Pugnaloni A., Espinosa E., Amenta F., Bonaf\u00e8 M., et al. Pleiotropic effects of polyphenols on glucose and lipid metabolism: Focus on clinical trials. Ageing Res. Rev. 2020;61:101074. doi: 10.1016/j.arr.2020.101074.", "ArticleIdList": ["10.1016/j.arr.2020.101074", "32335301"]}, {"Citation": "Ofosu F.K., Daliri E.B.M., Elahi F., Chelliah R., Lee B.H., Oh D.H. New insights on the use of polyphenols as natural preservatives and their emerging safety concerns. Front. Sustain. Food Syst. 2020;4:525810. doi: 10.3389/fsufs.2020.525810.", "ArticleIdList": ["10.3389/fsufs.2020.525810"]}, {"Citation": "Quideau S., Deffieux D., Douat-Casassus C., Pouys\u00e9gu L. Plant polyphenols: Chemical properties, biological activities, and synthesis. Angew. Chem. Int. Ed. 2011;50:586\u2013621. doi: 10.1002/anie.201000044.", "ArticleIdList": ["10.1002/anie.201000044", "21226137"]}, {"Citation": "Kumar N., Goel N. Phenolic acids: Natural versatile molecules with promising therapeutic applications. Biotechnol. Rep. 2019;24:e00370. doi: 10.1016/j.btre.2019.e00370.", "ArticleIdList": ["10.1016/j.btre.2019.e00370", "PMC6734135", "31516850"]}, {"Citation": "Tsao R. Chemistry and Biochemistry of Dietary Polyphenols. Nutrients. 2010;2:1231\u20131246. doi: 10.3390/nu2121231.", "ArticleIdList": ["10.3390/nu2121231", "PMC3257627", "22254006"]}, {"Citation": "Shrestha S., Zhang W., Smid S.D. Phlorotannins: A review on biosynthesis, chemistry and bioactivity. Food Biosci. 2021;39:100832. doi: 10.1016/j.fbio.2020.100832.", "ArticleIdList": ["10.1016/j.fbio.2020.100832"]}, {"Citation": "Guan H., Zhang W., Sun-Waterhouse D., Jiang Y., Li F., Waterhouse G.N., Li D. Phenolic-protein interactions in foods and post ingestion: Switches empowering health outcomes. Trends Food Sci. Technol. 2021;118:71\u201386. doi: 10.1016/j.tifs.2021.08.033.", "ArticleIdList": ["10.1016/j.tifs.2021.08.033"]}, {"Citation": "Mehany T., Khalifa I., Barakat H., Althwab S.A., Alharbi Y.M., El-Sohaimy S. Polyphenols as promising biologically active substances for preventing SARS-CoV-2: A review with research evidence and underlying mechanisms. Food Biosci. 2021;40:100891. doi: 10.1016/j.fbio.2021.100891.", "ArticleIdList": ["10.1016/j.fbio.2021.100891", "PMC7817466", "33495727"]}, {"Citation": "Chojnacka K., Witek-Krowiak A., Skrzypczak D., Mikula K., M\u0142ynarz P. Phytochemicals containing biologically active polyphenols as an effective agent against COVID-19-inducing coronavirus. J. Funct. Foods. 2020;73:104146. doi: 10.1016/j.jff.2020.104146.", "ArticleIdList": ["10.1016/j.jff.2020.104146", "PMC7392194", "32834835"]}, {"Citation": "El-Missiry M.A., Fekri A., Kesar L.A., Othman A.I. Polyphenols are potential nutritional adjuvants for targeting COVID-19. Phyther. Res. 2021;35:2879\u20132889. doi: 10.1002/ptr.6992.", "ArticleIdList": ["10.1002/ptr.6992", "33354848"]}, {"Citation": "P\u00e9rez de la Lastra J.M., Andr\u00e9s-Juan C., Plou F.J., P\u00e9rez-Lebe\u00f1a E. Impact of zinc, glutathione, and polyphenols as antioxidants in the immune response against SARS-CoV-2. Processes. 2021;9:506. doi: 10.3390/pr9030506.", "ArticleIdList": ["10.3390/pr9030506"]}, {"Citation": "Levy E., Delvin E., Marcil V., Spahis S. Can phytotherapy with polyphenols serve as a powerful approach for the prevention and therapy tool of novel coronavirus disease 2019 (COVID-19)? Am. J. Physiol.-Endocrinol. Metab. 2020;319:E689\u2013E708. doi: 10.1152/ajpendo.00298.2020.", "ArticleIdList": ["10.1152/ajpendo.00298.2020", "PMC7518070", "32755302"]}, {"Citation": "Giovinazzo G., Gerardi C., Uberti-Foppa C., Lopalco L. Can natural polyphenols help in reducing cytokine storm in COVID-19 patients? Molecules. 2020;25:5888. doi: 10.3390/molecules25245888.", "ArticleIdList": ["10.3390/molecules25245888", "PMC7763290", "33322757"]}, {"Citation": "Santos J.C., Ribeiro M.L., Gambero A. The impact of polyphenols-based diet on the inflammatory profile in COVID-19 elderly and obese patients. Front. Physiol. 2021;11:612268. doi: 10.3389/fphys.2020.612268.", "ArticleIdList": ["10.3389/fphys.2020.612268", "PMC7874176", "33584335"]}, {"Citation": "Limanaqi F., Busceti C.L., Biagioni F., Lazzeri G., Forte M., Schiavon S., Sciarretta S., Frati G., Fornai F. Cell clearing systems as targets of polyphenols in viral infections: Potential implications for COVID-19 pathogenesis. Antioxidants. 2020;9:1105. doi: 10.3390/antiox9111105.", "ArticleIdList": ["10.3390/antiox9111105", "PMC7697279", "33182802"]}, {"Citation": "Mhatre S., Srivastava T., Naik S., Patravale V. Antiviral activity of green tea and black tea polyphenols in prophylaxis and treatment of COVID-19: A review. Phytomedicine. 2021;85:153286. doi: 10.1016/j.phymed.2020.153286.", "ArticleIdList": ["10.1016/j.phymed.2020.153286", "PMC7367004", "32741697"]}, {"Citation": "Park J., Park R., Jang M., Park Y.-I. Therapeutic potential of EGCG, a green tea polyphenol, for treatment of coronavirus diseases. Life. 2021;11:197. doi: 10.3390/life11030197.", "ArticleIdList": ["10.3390/life11030197", "PMC8002208", "33806274"]}, {"Citation": "Milenkovic D., Ruskovska T., Rodriguez-Mateos A., Heiss C. Polyphenols could prevent SARS-CoV-2 infection by modulating the expression of miRNas in the host cells. Aging Dis. 2021;12:1169. doi: 10.14336/AD.2021.0223.", "ArticleIdList": ["10.14336/AD.2021.0223", "PMC8279534", "34341700"]}, {"Citation": "Liskova A., Koklesova L., Samec M., Abdellatif B., Zhai K., Siddiqui M., \u0160udomov\u00e1 M., Hassan S.T.S., Kudela E., Biringer K., et al. Targeting phytoprotection in the COVID-19-induced lung damage and associated systemic effects\u2014the evidence-based 3PM proposition to mitigate individual risks. EPMA J. 2021;12:325\u2013347. doi: 10.1007/s13167-021-00249-y.", "ArticleIdList": ["10.1007/s13167-021-00249-y", "PMC8329620", "34367380"]}, {"Citation": "Del Bo\u2019 C., Bernardi S., Marino M., Porrini M., Tucci M., Guglielmetti S., Cherubini A., Carrieri B., Kirkup B., Kroon P., et al. Systematic review on polyphenol intake and health outcomes: Is there sufficient evidence to define a health-promoting polyphenol-rich dietary Pattern? Nutrients. 2019;11:1355. doi: 10.3390/nu11061355.", "ArticleIdList": ["10.3390/nu11061355", "PMC6627994", "31208133"]}, {"Citation": "Cardona F., Andr\u00e9s-Lacueva C., Tulipani S., Tinahones F.J., Queipo-Ortu\u00f1o M.I. Benefits of polyphenols on gut microbiota and implications in human health. J. Nutr. Biochem. 2013;24:1415\u20131422. doi: 10.1016/j.jnutbio.2013.05.001.", "ArticleIdList": ["10.1016/j.jnutbio.2013.05.001", "23849454"]}, {"Citation": "Goszcz K., Deakin S.J., Duthie G.G., Stewart D., Leslie S.J., Megson I.L. Antioxidants in cardiovascular therapy: Panacea or false hope? Front. Cardiovasc. Med. 2015;2:29. doi: 10.3389/fcvm.2015.00029.", "ArticleIdList": ["10.3389/fcvm.2015.00029", "PMC4671344", "26664900"]}, {"Citation": "Cuicchi D., Lazzarotto T., Poggioli G. Fecal-oral transmission of SARS-CoV-2: Review of laboratory-confirmed virus in gastrointestinal system. Int. J. Colorectal Dis. 2021;36:437\u2013444. doi: 10.1007/s00384-020-03785-7.", "ArticleIdList": ["10.1007/s00384-020-03785-7", "PMC7556558", "33057894"]}, {"Citation": "Da Luz B.B., de Oliveira N.M.T., dos Santos I.W.F., Paza L.Z., Braga L.L.V.D.M., Platner F.D.S., Werner M.F.D.F., Fernandes E.S., Maria-Ferreira D. An overview of the gut side of the SARS-CoV-2 infection. Intestig. Res. 2020;19:379\u2013385. doi: 10.5217/ir.2020.00087.", "ArticleIdList": ["10.5217/ir.2020.00087", "PMC8566822", "33142370"]}, {"Citation": "Blaser A.R., Gunst J., Arabi Y.M. The gut in COVID-19. Intensive Care Med. 2021;47:1024\u20131027. doi: 10.1007/s00134-021-06461-8.", "ArticleIdList": ["10.1007/s00134-021-06461-8", "PMC8265290", "34240234"]}, {"Citation": "Bennick A. Interaction of plant polyphenols with salivary proteins. Crit. Rev. Oral Biol. Med. 2002;13:184\u2013196. doi: 10.1177/154411130201300208.", "ArticleIdList": ["10.1177/154411130201300208", "12097360"]}, {"Citation": "Davies H.S., Pudney P.D.A., Georgiades P., Waigh T.A., Hodson N.W., Ridley C.E., Blanch E.W., Thornton D.J. Reorganisation of the Salivary Mucin Network by Dietary Components: Insights from Green Tea Polyphenols. PLoS ONE. 2014;9:e108372. doi: 10.1371/journal.pone.0108372.", "ArticleIdList": ["10.1371/journal.pone.0108372", "PMC4180932", "25264771"]}, {"Citation": "Xu H., Zhong L., Deng J., Peng J., Dan H., Zeng X., Li T., Chen Q. High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa. Int. J. Oral Sci. 2020;12:8. doi: 10.1038/s41368-020-0074-x.", "ArticleIdList": ["10.1038/s41368-020-0074-x", "PMC7039956", "32094336"]}, {"Citation": "Perlman S. Another Decade, Another Coronavirus. N. Engl. J. Med. 2020;382:760\u2013762. doi: 10.1056/NEJMe2001126.", "ArticleIdList": ["10.1056/NEJMe2001126", "PMC7121143", "31978944"]}, {"Citation": "Khailany R.A., Safdar M., Ozaslan M. Genomic characterization of a novel SARS-CoV-2. Gene Rep. 2020;19:100682. doi: 10.1016/j.genrep.2020.100682.", "ArticleIdList": ["10.1016/j.genrep.2020.100682", "PMC7161481", "32300673"]}, {"Citation": "Paraskevis D., Kostaki E.G., Magiorkinis G., Panayiotakopoulos G., Sourvinos G., Tsiodras S. Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event. Infect. Genet. Evol. 2020;79:104212. doi: 10.1016/j.meegid.2020.104212.", "ArticleIdList": ["10.1016/j.meegid.2020.104212", "PMC7106301", "32004758"]}, {"Citation": "Dhama K., Patel S.K., Sharun K., Pathak M., Tiwari R., Yatoo M.I., Malik Y.S., Sah R., Rabaan A.A., Panwar P.K., et al. SARS-CoV-2 jumping the species barrier: Zoonotic lessons from SARS, MERS and recent advances to combat this pandemic virus. Travel Med. Infect. Dis. 2020;37:101830. doi: 10.1016/j.tmaid.2020.101830.", "ArticleIdList": ["10.1016/j.tmaid.2020.101830", "PMC7396141", "32755673"]}, {"Citation": "Hoffmann M., Kleine-Weber H., Schroeder S., Kr\u00fcger N., Herrler T., Erichsen S., Schiergens T.S., Herrler G., Wu N.-H., Nitsche A., et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181:271\u2013280. doi: 10.1016/j.cell.2020.02.052.", "ArticleIdList": ["10.1016/j.cell.2020.02.052", "PMC7102627", "32142651"]}, {"Citation": "Shang J., Wan Y., Luo C., Ye G., Geng Q., Auerbach A., Li F. Cell entry mechanisms of SARS-CoV-2. Proc. Natl. Acad. Sci. USA. 2020;117:11727\u201311734. doi: 10.1073/pnas.2003138117.", "ArticleIdList": ["10.1073/pnas.2003138117", "PMC7260975", "32376634"]}, {"Citation": "Zhang Q., Xiang R., Huo S., Zhou Y., Jiang S., Wang Q., Yu F. Molecular mechanism of interaction between SARS-CoV-2 and host cells and interventional therapy. Signal. Transduct. Target. Ther. 2021;6:233. doi: 10.1038/s41392-021-00653-w.", "ArticleIdList": ["10.1038/s41392-021-00653-w", "PMC8193598", "34117216"]}, {"Citation": "Liu C., Zhou Q., Li Y., Garner L.V., Watkins S.P., Carter L.J., Smoot J., Gregg A.C., Daniels A.D., Jervey S., et al. Research and development on therapeutic agents and vaccines for COVID-19 and related human coronavirus diseases. ACS Cent. Sci. 2020;6:315\u2013331. doi: 10.1021/acscentsci.0c00272.", "ArticleIdList": ["10.1021/acscentsci.0c00272", "PMC10467574", "32226821"]}, {"Citation": "Satarker S., Nampoothiri M. Structural proteins in severe acute respiratory syndrome coronavirus-2. Arch. Med. Res. 2020;51:482\u2013491. doi: 10.1016/j.arcmed.2020.05.012.", "ArticleIdList": ["10.1016/j.arcmed.2020.05.012", "PMC7247499", "32493627"]}, {"Citation": "Huang Y., Yang C., Xu X.F., Xu W., Liu S.W. Structural and functional properties of SARS-CoV-2 spike protein: Potential antivirus drug development for COVID-19. Acta Pharmacol. Sin. 2020;41:1141\u20131149. doi: 10.1038/s41401-020-0485-4.", "ArticleIdList": ["10.1038/s41401-020-0485-4", "PMC7396720", "32747721"]}, {"Citation": "Wrapp D., Wang N., Corbett K.S., Goldsmith J.A., Hsieh C.L., Abiona O., Graham B.S., McLellan J.S. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science. 2020;367:1260\u20131263. doi: 10.1126/science.abb2507.", "ArticleIdList": ["10.1126/science.abb2507", "PMC7164637", "32075877"]}, {"Citation": "Xu C., Wang Y., Liu C., Zhang C., Han W., Hong X., Wang Y., Hong Q., Wang S., Zhao Q., et al. Conformational dynamics of SARS-CoV-2 trimeric spike glycoprotein in complex with receptor ACE2 revealed by cryo-EM. Sci. Adv. 2021;7:eabe5575. doi: 10.1126/sciadv.abe5575.", "ArticleIdList": ["10.1126/sciadv.abe5575", "PMC7775788", "33277323"]}, {"Citation": "Xia S., Yan L., Xu W., Agrawal A.S., Algaissi A., Tseng C.-T.K., Wang Q., Du L., Tan W., Wilson I.A., et al. A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike. Sci. Adv. 2019;5:eaav4580. doi: 10.1126/sciadv.aav4580.", "ArticleIdList": ["10.1126/sciadv.aav4580", "PMC6457931", "30989115"]}, {"Citation": "Jin Z., Du X., Xu Y., Deng Y., Liu M., Zhao Y., Zhang B., Li X., Zhang L., Peng C., et al. Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors. Nature. 2020;582:289\u2013293. doi: 10.1038/s41586-020-2223-y.", "ArticleIdList": ["10.1038/s41586-020-2223-y", "32272481"]}, {"Citation": "Pluskota-Karwatka D., Hoffmann M., Barciszewski J. Reducing SARS-CoV-2 pathological protein activity with small molecules. J. Pharm. Anal. 2021;11:383\u2013397. doi: 10.1016/j.jpha.2021.03.012.", "ArticleIdList": ["10.1016/j.jpha.2021.03.012", "PMC8020608", "33842018"]}, {"Citation": "Shin D., Mukherjee R., Grewe D., Bojkova D., Baek K., Bhattacharya A., Schulz L., Widera M., Mehdipour A.R., Tascher G., et al. Papain-like protease regulates SARS-CoV-2 viral spread and innate immunity. Nature. 2020;587:657\u2013662. doi: 10.1038/s41586-020-2601-5.", "ArticleIdList": ["10.1038/s41586-020-2601-5", "PMC7116779", "32726803"]}, {"Citation": "Osipiuk J., Azizi S.-A., Dvorkin S., Endres M., Jedrzejczak R., Jones K.A., Kang S., Kathayat R.S., Kim Y., Lisnyak V.G., et al. Structure of papain-like protease from SARS-CoV-2 and its complexes with non-covalent inhibitors. Nat. Commun. 2021;12:743. doi: 10.1038/s41467-021-21060-3.", "ArticleIdList": ["10.1038/s41467-021-21060-3", "PMC7854729", "33531496"]}, {"Citation": "Heustess A.M., Allard M.A., Thompson D.K., Fasinu P.S. Clinical management of COVID-19: A review of pharmacological treatment options. Pharmaceuticals. 2021;14:520. doi: 10.3390/ph14060520.", "ArticleIdList": ["10.3390/ph14060520", "PMC8229327", "34071185"]}, {"Citation": "Zhou Y., Hou Y., Shen J., Huang Y., Martin W., Cheng F. Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2. Cell Discov. 2020;6:14. doi: 10.1038/s41421-020-0153-3.", "ArticleIdList": ["10.1038/s41421-020-0153-3", "PMC7073332", "32194980"]}, {"Citation": "Gordon D.E., Jang G.M., Bouhaddou M., Xu J., Obernier K., White K.M., O\u2019Meara M.J., Rezelj V.V., Guo J.Z., Swaney D.L., et al. A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. Nature. 2020;583:459\u2013468. doi: 10.1038/s41586-020-2286-9.", "ArticleIdList": ["10.1038/s41586-020-2286-9", "PMC7431030", "32353859"]}, {"Citation": "Mirabelli C., Wotring J.W., Zhang C.J., McCarty S.M., Fursmidt R., Pretto C.D., Qiao Y., Zhang Y., Frum T., Kadambi N.S., et al. Morphological cell profiling of SARS-CoV-2 infection identifies drug repurposing candidates for COVID-19. Proc. Natl. Acad. Sci. USA. 2021;118:e2105815118. doi: 10.1073/pnas.2105815118.", "ArticleIdList": ["10.1073/pnas.2105815118", "PMC8433531", "34413211"]}, {"Citation": "Fuzimoto A.D., Isidoro C. The antiviral and coronavirus-host protein pathways inhibiting properties of herbs and natural compounds\u2014Additional weapons in the fight against the COVID-19 pandemic? J. Tradit. Complement. Med. 2020;10:405\u2013419. doi: 10.1016/j.jtcme.2020.05.003.", "ArticleIdList": ["10.1016/j.jtcme.2020.05.003", "PMC7260130", "32691005"]}, {"Citation": "Sayed A.M., Khattab A.R., AboulMagd A.M., Hassan H.M., Rateb M.E., Zaid H., Abdelmohsen U.R. Nature as a treasure trove of potential anti-SARS-CoV drug leads: A structural/mechanistic rationale. RSC Adv. 2020;10:19790\u201319802. doi: 10.1039/D0RA04199H.", "ArticleIdList": ["10.1039/D0RA04199H", "PMC9122629", "35685913"]}, {"Citation": "Yahfoufi N., Alsadi N., Jambi M., Matar C. The immunomodulatory and anti-inflammatory role of polyphenols. Nutrients. 2018;10:1618. doi: 10.3390/nu10111618.", "ArticleIdList": ["10.3390/nu10111618", "PMC6266803", "30400131"]}, {"Citation": "Ghosh R., Chakraborty A., Biswas A., Chowdhuri S. Evaluation of green tea polyphenols as novel corona virus (SARS-CoV-2) main protease (Mpro) inhibitors\u2014An in silico docking and molecular dynamics simulation study. J. Biomol. Struct. Dyn. 2021;39:4362\u20134374. doi: 10.1080/07391102.2020.1779818.", "ArticleIdList": ["10.1080/07391102.2020.1779818", "PMC7332865", "32568613"]}, {"Citation": "Dalan R. Is DPP4 inhibition a comrade or adversary in COVID-19 infection. Diabetes Res. Clin. Pract. 2020;164:108216. doi: 10.1016/j.diabres.2020.108216.", "ArticleIdList": ["10.1016/j.diabres.2020.108216", "PMC7235575", "32416120"]}, {"Citation": "Singh R., Gautam A., Chandel S., Ghosh A., Dey D., Roy S., Ravichandiran V., Ghosh D. Protease inhibitory effect of natural polyphenolic compounds on SARS-CoV-2: An In silico Study. Molecules. 2020;25:4604. doi: 10.3390/molecules25204604.", "ArticleIdList": ["10.3390/molecules25204604", "PMC7587198", "33050360"]}, {"Citation": "Vijayakumar B.G., Ramesh D., Joji A., Jayachandra prakasan J., Kannan T. In silico pharmacokinetic and molecular docking studies of natural flavonoids and synthetic indole chalcones against essential proteins of SARS-CoV-2. Eur. J. Pharmacol. 2020;886:173448. doi: 10.1016/j.ejphar.2020.173448.", "ArticleIdList": ["10.1016/j.ejphar.2020.173448", "PMC7406432", "32768503"]}, {"Citation": "Wu W., Li R., Li X., He J., Jiang S., Liu S., Yang J. Quercetin as an antiviral agent inhibits influenza A Virus (IAV) entry. Viruses. 2016;8:6. doi: 10.3390/v8010006.", "ArticleIdList": ["10.3390/v8010006", "PMC4728566", "26712783"]}, {"Citation": "Zandi K., Teoh B.-T., Sam S.-S., Wong P.-F., Mustafa M.R., AbuBakar S. Antiviral activity of four types of bioflavonoid against dengue virus type-2. Virol. J. 2011;8:560. doi: 10.1186/1743-422X-8-560.", "ArticleIdList": ["10.1186/1743-422X-8-560", "PMC3271998", "22201648"]}, {"Citation": "Chen L., Li J., Luo C., Liu H., Xu W., Chen G., Liew O.W., Zhu W., Puah C.M., Shen X., et al. Binding interaction of quercetin-3-\u03b2-galactoside and its synthetic derivatives with SARS-CoV 3CLpro: Structure\u2013activity relationship studies reveal salient pharmacophore features. Bioorg. Med. Chem. 2006;14:8295\u20138306. doi: 10.1016/j.bmc.2006.09.014.", "ArticleIdList": ["10.1016/j.bmc.2006.09.014", "PMC7125754", "17046271"]}, {"Citation": "Abian O., Ortega-Alarcon D., Jimenez-Alesanco A., Ceballos-Laita L., Vega S., Reyburn H.T., Rizzuti B., Velazquez-Campoy A. Structural stability of SARS-CoV-2 3CLpro and identification of quercetin as an inhibitor by experimental screening. Int. J. Biol. Macromol. 2020;164:1693\u20131703. doi: 10.1016/j.ijbiomac.2020.07.235.", "ArticleIdList": ["10.1016/j.ijbiomac.2020.07.235", "PMC7395220", "32745548"]}, {"Citation": "Nguyen T.T.H., Woo H.J., Kang H.K., Nguyen V.D., Kim Y.M., Kim D.W., Ahn S.A., Xia Y., Kim D. Flavonoid-mediated inhibition of SARS coronavirus 3C-like protease expressed in Pichia pastoris. Biotechnol. Lett. 2012;34:831\u2013838. doi: 10.1007/s10529-011-0845-8.", "ArticleIdList": ["10.1007/s10529-011-0845-8", "PMC7087583", "22350287"]}, {"Citation": "Kuba K., Imai Y., Rao S., Gao H., Guo F., Guan B., Huan Y., Yang P., Zhang Y., Deng W., et al. A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury. Nat. Med. 2005;11:875\u2013879. doi: 10.1038/nm1267.", "ArticleIdList": ["10.1038/nm1267", "PMC7095783", "16007097"]}, {"Citation": "Liu X., Raghuvanshi R., Ceylan F.D., Bolling B.W. Quercetin and its metabolites inhibit recombinant human angiotensin-converting enzyme 2 (ACE2) activity. J. Agric. Food Chem. 2020;68:13982\u201313989. doi: 10.1021/acs.jafc.0c05064.", "ArticleIdList": ["10.1021/acs.jafc.0c05064", "33179911"]}, {"Citation": "Jo S., Kim S., Shin D.H., Kim M.-S. Inhibition of SARS-CoV 3CL protease by flavonoids. J. Enzym. Inhib. Med. Chem. 2020;35:145\u2013151. doi: 10.1080/14756366.2019.1690480.", "ArticleIdList": ["10.1080/14756366.2019.1690480", "PMC6882434", "31724441"]}, {"Citation": "Jo S., Kim S., Kim D.Y., Kim M.-S., Shin D.H. Flavonoids with inhibitory activity against SARS-CoV-2 3CLpro. J. Enzym. Inhib. Med. Chem. 2020;35:1539\u20131544. doi: 10.1080/14756366.2020.1801672.", "ArticleIdList": ["10.1080/14756366.2020.1801672", "PMC7470085", "32746637"]}, {"Citation": "Wang S.-C., Chen Y., Wang Y.-C., Wang W.-J., Yang C.-S., Tsai C.-L., Hou M.-H., Chen H.-F., Shen Y.-C., Hung M.-C. Tannic acid suppresses SARS-CoV-2 as a dual inhibitor of the viral main protease and the cellular TMPRSS2 protease. Am. J. Cancer Res. 2020;10:4538\u20134546.", "ArticleIdList": ["PMC7783773", "33415017"]}, {"Citation": "Wen C.C., Kuo Y.H., Jan J.T., Liang P.H., Wang S.Y., Liu H.G., Lee C.K., Chang S.T., Kuo C.J., Lee S.S., et al. Specific plant terpenoids and lignoids possess potent antiviral activities against severe acute respiratory syndrome coronavirus. J. Med. Chem. 2007;50:4087\u20134095. doi: 10.1021/jm070295s.", "ArticleIdList": ["10.1021/jm070295s", "17663539"]}, {"Citation": "Guijarro-Real C., Plazas M., Rodr\u00edguez-Burruezo A., Prohens J., Fita A. Potential in vitro inhibition of selected plant extracts against SARS-CoV-2 chymotripsin-like protease (3CLPro) activity. Foods. 2021;10:1503. doi: 10.3390/foods10071503.", "ArticleIdList": ["10.3390/foods10071503", "PMC8304378", "34209659"]}, {"Citation": "Delre P., Caporuscio F., Saviano M., Mangiatordi G.F. Repurposing known drugs as covalent and non-covalent inhibitors of the SARS-CoV-2 papain-like protease. Front. Chem. 2020;8:594009. doi: 10.3389/fchem.2020.594009.", "ArticleIdList": ["10.3389/fchem.2020.594009", "PMC7701290", "33304884"]}, {"Citation": "Dourado D., Freire D.T., Pereira D.T., Amaral-Machado L., Alencar \u00c9.N., de Barros A.L.B., Egito E.S.T. Will curcumin nanosystems be the next promising antiviral alternatives in COVID-19 treatment trials? Biomed. Pharmacother. 2021;139:111578. doi: 10.1016/j.biopha.2021.111578.", "ArticleIdList": ["10.1016/j.biopha.2021.111578", "PMC8023207", "33848774"]}, {"Citation": "Park J.Y., Kim J.H., Kwon J.M., Kwon H.J., Jeong H.J., Kim Y.M., Kim D., Lee W.S., Ryu Y.B. Dieckol, a SARS-CoV 3CLpro inhibitor, isolated from the edible brown algae Ecklonia cava. Bioorganic Med. Chem. 2013;21:3730\u20133737. doi: 10.1016/j.bmc.2013.04.026.", "ArticleIdList": ["10.1016/j.bmc.2013.04.026", "PMC7126891", "23647823"]}, {"Citation": "Nguyen T.T.H., Jung J.H., Kim M.K., Lim S., Choi J.M., Chung B., Kim D.W., Kim D. The inhibitory effects of plant derivate polyphenols on the main protease of SARS coronavirus 2 and their structure\u2013activity relationship. Molecules. 2021;26:1924. doi: 10.3390/molecules26071924.", "ArticleIdList": ["10.3390/molecules26071924", "PMC8036510", "33808054"]}, {"Citation": "Jang M., Park Y.I., Cha Y.E., Park R., Namkoong S., Lee J.I., Park J. Tea polyphenols EGCG and theaflavin inhibit the activity of SARS-CoV-2 3CL-protease in vitro. Evid.-Based Complement. Altern. Med. 2020;2020:5630838. doi: 10.1155/2020/5630838.", "ArticleIdList": ["10.1155/2020/5630838", "PMC7499281", "32963564"]}, {"Citation": "Xiao T., Cui M., Zheng C., Wang M., Sun R., Gao D., Bao J., Ren S., Yang B., Lin J., et al. Myricetin inhibits SARS-CoV-2 viral replication by targeting Mpro and ameliorates pulmonary inflammation. Front. Pharmacol. 2021;12:669642. doi: 10.3389/fphar.2021.669642.", "ArticleIdList": ["10.3389/fphar.2021.669642", "PMC8248548", "34220507"]}, {"Citation": "Yu M.-S., Lee J., Lee J.M., Kim Y., Chin Y.-W., Jee J.-G., Keum Y.-S., Jeong Y.-J. Identification of myricetin and scutellarein as novel chemical inhibitors of the SARS coronavirus helicase, nsP13. Bioorg. Med. Chem. Lett. 2012;22:4049\u20134054. doi: 10.1016/j.bmcl.2012.04.081.", "ArticleIdList": ["10.1016/j.bmcl.2012.04.081", "PMC7127438", "22578462"]}, {"Citation": "Park J.Y., Ko J.A., Kim D.W., Kim Y.M., Kwon H.J., Jeong H.J., Kim C.Y., Park K.H., Lee W.S., Ryu Y.B. Chalcones isolated from Angelica keiskei inhibit cysteine proteases of SARS-CoV. J. Enzym. Inhib. Med. Chem. 2016;31:23\u201330. doi: 10.3109/14756366.2014.1003215.", "ArticleIdList": ["10.3109/14756366.2014.1003215", "25683083"]}, {"Citation": "Park J., Yuk H.J., Ryu H.W., Lim S.H., Kim K.S., Park K.H., Ryu Y.B., Lee W.S. Evaluation of polyphenols from Broussonetia papyrifera as coronavirus protease inhibitors. J. Enzym. Inhib. Med. Chem. 2017;32:504\u2013512. doi: 10.1080/14756366.2016.1265519.", "ArticleIdList": ["10.1080/14756366.2016.1265519", "PMC6010046", "28112000"]}, {"Citation": "Kim D.W., Seo K.H., Curtis-Long M.J., Oh K.Y., Oh J.-W., Cho J.K., Lee K.H., Park K.H. Phenolic phytochemical displaying SARS-CoV papain-like protease inhibition from the seeds of Psoralea corylifolia. J. Enzym. Inhib. Med. Chem. 2014;29:59\u201363. doi: 10.3109/14756366.2012.753591.", "ArticleIdList": ["10.3109/14756366.2012.753591", "23323951"]}, {"Citation": "Ibrahim T.M., Ismail M.I., Bauer M.R., Bekhit A.A., Boeckler F.M. Supporting SARS-CoV-2 papain-like protease drug discovery: In silico methods and benchmarking. Front. Chem. 2020;8:592289. doi: 10.3389/fchem.2020.592289.", "ArticleIdList": ["10.3389/fchem.2020.592289", "PMC7674952", "33251185"]}, {"Citation": "Huynh T., Cornell W., Luan B. In silico Exploration of inhibitors for SARS-CoV-2\u2032s papain-like protease. Front. Chem. 2021;8:624163. doi: 10.3389/fchem.2020.624163.", "ArticleIdList": ["10.3389/fchem.2020.624163", "PMC7889802", "33614597"]}, {"Citation": "Goc A., Sumera W., Rath M., Niedzwiecki A. Phenolic compounds disrupt spike-mediated receptor-binding and entry of SARS-CoV-2 pseudo-virions. PLoS ONE. 2021;16:e0253489. doi: 10.1371/journal.pone.0253489.", "ArticleIdList": ["10.1371/journal.pone.0253489", "PMC8211150", "34138966"]}, {"Citation": "Tito A., Colantuono A., Pirone L., Pedone E., Intartaglia D., Giamundo G., Conte I., Vitaglione P., Apone F. Pomegranate peel extract as an inhibitor of SARS-CoV-2 spike binding to human ACE2 receptor (in vitro): A promising source of novel antiviral drugs. Front. Chem. 2021;9:638187. doi: 10.3389/fchem.2021.638187.", "ArticleIdList": ["10.3389/fchem.2021.638187", "PMC8114579", "33996744"]}, {"Citation": "Ho T.Y., Wu S.L., Chen J.C., Li C.C., Hsiang C.Y. Emodin blocks the SARS coronavirus spike protein and angiotensin-converting enzyme 2 interaction. Antivir. Res. 2007;74:92\u2013101. doi: 10.1016/j.antiviral.2006.04.014.", "ArticleIdList": ["10.1016/j.antiviral.2006.04.014", "PMC7114332", "16730806"]}, {"Citation": "Dellafiora L., Dorne J.L.C.M., Galaverna G., Dall\u2019Asta C. Preventing the interaction between coronaviruses spike protein and angiotensin I converting enzyme 2: An in silico mechanistic case study on emodin as a potential model compound. Appl. Sci. 2020;10:6358. doi: 10.3390/app10186358.", "ArticleIdList": ["10.3390/app10186358"]}, {"Citation": "Gianchecchi E., Fierabracci A. Insights on the effects of resveratrol and some of its derivatives in cancer and autoimmunity: A molecule with a dual activity. Antioxidants. 2020;9:91. doi: 10.3390/antiox9020091.", "ArticleIdList": ["10.3390/antiox9020091", "PMC7070243", "31978952"]}, {"Citation": "Banez M.J., Geluz M.I., Chandra A., Hamdan T., Biswas O.S., Bryan N.S., Von Schwarz E.R. A systemic review on the antioxidant and anti-inflammatory effects of resveratrol, curcumin, and dietary nitric oxide supplementation on human cardiovascular health. Nutr. Res. 2020;78:11\u201326. doi: 10.1016/j.nutres.2020.03.002.", "ArticleIdList": ["10.1016/j.nutres.2020.03.002", "32428778"]}, {"Citation": "Gligorijevi\u0107 N., Stani\u0107-Vu\u010dini\u0107 D., Radomirovi\u0107 M., Stojadinovi\u0107 M., Khulal U., Nedi\u0107 O., \u0106irkovi\u0107 Veli\u010dkovi\u0107 T. Role of resveratrol in prevention and control of cardiovascular disorders and cardiovascular complications related to COVID-19 disease: Mode of action and approaches explored to increase its bioavailability. Molecules. 2021;26:2834. doi: 10.3390/molecules26102834.", "ArticleIdList": ["10.3390/molecules26102834", "PMC8151233", "34064568"]}, {"Citation": "Ramdani L.H., Bachari K. Potential therapeutic effects of Resveratrol against SARS-CoV-2. Acta Virol. 2020;64:276\u2013280. doi: 10.4149/av_2020_309.", "ArticleIdList": ["10.4149/av_2020_309", "32985211"]}, {"Citation": "Palamara A.T., Nencioni L., Aquilano K., De Chiara G., Hernandez L., Cozzolino F., Ciriolo M.R., Garaci E. Inhibition of influenza A virus replication by resveratrol. J. Infect. Dis. 2005;191:1719\u20131729. doi: 10.1086/429694.", "ArticleIdList": ["10.1086/429694", "15838800"]}, {"Citation": "Mastromarino P., Capobianco D., Cannata F., Nardis C., Mattia E., De Leo A., Restignoli R., Francioso A., Mosca L. Resveratrol inhibits rhinovirus replication and expression of inflammatory mediators in nasal epithelia. Antivir. Res. 2015;123:15\u201321. doi: 10.1016/j.antiviral.2015.08.010.", "ArticleIdList": ["10.1016/j.antiviral.2015.08.010", "26296578"]}, {"Citation": "Mohd A., Zainal N., Tan K.K., AbuBakar S. Resveratrol affects Zika virus replication in vitro. Sci. Rep. 2019;9:14336. doi: 10.1038/s41598-019-50674-3.", "ArticleIdList": ["10.1038/s41598-019-50674-3", "PMC6778103", "31586088"]}, {"Citation": "Lin S.C., Ho C.T., Chuo W.H., Li S.M., Wang T.T., Lin C.C. Effective inhibition of MERS-CoV infection by resveratrol. Bmc Infect. Dis. 2017;17:144. doi: 10.1186/s12879-017-2253-8.", "ArticleIdList": ["10.1186/s12879-017-2253-8", "PMC5307780", "28193191"]}, {"Citation": "Kim E.N., Kim M.Y., Lim J.H., Kim Y., Shin S.J., Park C.W., Kim Y.S., Chang Y.S., Yoon H.E., Choi B.S. The protective effect of resveratrol on vascular aging by modulation of the renine-angiotensin system. Atherosclerosis. 2018;270:123\u2013131. doi: 10.1016/j.atherosclerosis.2018.01.043.", "ArticleIdList": ["10.1016/j.atherosclerosis.2018.01.043", "29407880"]}, {"Citation": "Cheng H., Wang Y., Wang G.Q. Organ-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of COVID-19. J. Med. Virol. 2020;92:726\u2013730. doi: 10.1002/jmv.25785.", "ArticleIdList": ["10.1002/jmv.25785", "PMC7317908", "32221983"]}, {"Citation": "Wahedi H.M., Ahmad S., Abbasi S.W. Stilbene-based natural compounds as promising drug candidates against COVID-19. J. Biomol. Struct. Dyn. 2021;39:3225\u20133234. doi: 10.1080/07391102.2020.1762743.", "ArticleIdList": ["10.1080/07391102.2020.1762743", "32345140"]}, {"Citation": "Yang M., Wei J., Huang T., Lei L., Shen C., Lai J., Yang M., Liu L., Yang Y., Liu G., et al. Resveratrol inhibits the replication of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in cultured Vero cells. Phyther. Res. 2021;35:1127\u20131129. doi: 10.1002/ptr.6916.", "ArticleIdList": ["10.1002/ptr.6916", "PMC7753598", "33222316"]}, {"Citation": "Pasquereau S., Nehme Z., Haidar Ahmad S., Daouad F., Van Assche J., Wallet C., Schwartz C., Rohr O., Morot-Bizot S., Herbein G. Resveratrol inhibits HCoV-229E and SARS-CoV-2 coronavirus replication in vitro. Viruses. 2021;13:354. doi: 10.3390/v13020354.", "ArticleIdList": ["10.3390/v13020354", "PMC7926471", "33672333"]}, {"Citation": "ter Ellen B.M., Dinesh Kumar N., Bouma E.M., Troost B., van de Pol D.P.I., van der Ende-Metselaar H.H., Apperloo L., van Gosliga D., van den Berge M., Nawijn M.C., et al. Resveratrol and pterostilbene inhibit SARS-CoV-2 replication in air\u2013liquid interface cultured human primary bronchial epithelial cells. Viruses. 2021;13:1335. doi: 10.3390/v13071335.", "ArticleIdList": ["10.3390/v13071335", "PMC8309965", "34372541"]}, {"Citation": "Nagao K., Jinnouchi T., Kai S., Yanagita T. Pterostilbene, a dimethylated analog of resveratrol, promotes energy metabolism in obese rats. J. Nutr. Biochem. 2017;43:151\u2013155. doi: 10.1016/j.jnutbio.2017.02.009.", "ArticleIdList": ["10.1016/j.jnutbio.2017.02.009", "28319852"]}, {"Citation": "Tsvetkov V., Varizhuk A., Kozlovskaya L., Shtro A., Lebedeva O., Komissarov A., Vedekhina T., Manuvera V., Zubkova O., Eremeev A., et al. EGCG as an anti-SARS-CoV-2 agent: Preventive versus therapeutic potential against original and mutant virus. Biochimie. 2021;191:27\u201332. doi: 10.1016/j.biochi.2021.08.003.", "ArticleIdList": ["10.1016/j.biochi.2021.08.003", "PMC8353982", "34389380"]}, {"Citation": "Abd El-Aziz T.M., Stockand J.D. Recent progress and challenges in drug development against COVID-19 coronavirus (SARS-CoV-2)\u2014An update on the status. Infect. Genet. Evol. 2020;83:104327. doi: 10.1016/j.meegid.2020.104327.", "ArticleIdList": ["10.1016/j.meegid.2020.104327", "PMC7166307", "32320825"]}, {"Citation": "Bettuzzi S., Gabba L., Cataldo S. Efficacy of a polyphenolic, standardized green tea extract for the treatment of COVID-19 syndrome: A proof-of-principle study. COVID. 2021;1:2. doi: 10.3390/covid1010002.", "ArticleIdList": ["10.3390/covid1010002"]}, {"Citation": "Bocchi L., Savi M., Naponelli V., Vilella R., Sgarbi G., Baracca A., Solaini G., Bettuzzi S., Rizzi F., Stilli D. Long-term oral administration of theaphenon-e improves cardiomyocyte mechanics and calcium dynamics by affecting phospholamban phosphorylation and ATP production. Cell. Physiol. Biochem. 2018;47:1230\u20131243. doi: 10.1159/000490219.", "ArticleIdList": ["10.1159/000490219", "29913456"]}, {"Citation": "Brausi M., Rizzi F., Bettuzzi S. Chemoprevention of human prostate cancer by green tea catechins: Two years later. a follow-up update. Eur. Urol. 2008;54:472\u2013473. doi: 10.1016/j.eururo.2008.03.100.", "ArticleIdList": ["10.1016/j.eururo.2008.03.100", "18406041"]}, {"Citation": "Hara Y. Tea catechins and their applications as supplements and pharmaceutics. Pharmacol. Res. 2011;64:100\u2013104. doi: 10.1016/j.phrs.2011.03.018.", "ArticleIdList": ["10.1016/j.phrs.2011.03.018", "21507345"]}, {"Citation": "Tatti S., Swinehart J.M., Thielert C., Tawfik H., Mescheder A., Beutner K.R. Sinecatechins, a Defined Green Tea Extract, in the Treatment of External Anogenital Warts. Obstet. Gynecol. 2008;111:1371\u20131379. doi: 10.1097/AOG.0b013e3181719b60.", "ArticleIdList": ["10.1097/AOG.0b013e3181719b60", "18515521"]}, {"Citation": "Younes M., Aggett P., Aguilar F., Crebelli R., Dusemund B., Filipi\u010d M., Frutos M.J., Galtier P., Gott D., Gundert-Remy U., et al. Scientific opinion on the safety of green tea catechins. EFSA J. 2018;16:5239. doi: 10.2903/j.efsa.2018.5239.", "ArticleIdList": ["10.2903/j.efsa.2018.5239", "PMC7009618", "32625874"]}, {"Citation": "Mancuso P., Venturelli F., Vicentini M., Perilli C., Larosa E., Bisaccia E., Bedeschi E., Zerbini A., Rossi P.G. Temporal profile and determinants of viral shedding and of viral clearance confirmation on nasopharyngeal swabs from SARS-CoV-2-positive subjects: A population-based prospective cohort study in Reggio Emilia, Italy. BMJ Open. 2020;10:e040380. doi: 10.1136/bmjopen-2020-040380.", "ArticleIdList": ["10.1136/bmjopen-2020-040380", "PMC7477995", "32878768"]}, {"Citation": "Yamada H., Tateishi M., Harada K., Ohashi T., Shimizu T., Atsumi T., Komagata Y., Iijima H., Komiyama K., Watanabe H.A. Randomized clinical study of tea catechin inhalation effects on methicillin-resistant staphylococcus aureus in disabled elderly patients. J. Am. Med. Dir. Assoc. 2006;7:79\u201383. doi: 10.1016/j.jamda.2005.06.002.", "ArticleIdList": ["10.1016/j.jamda.2005.06.002", "16461248"]}, {"Citation": "Salehi B., Stojanovi\u0107-Radi\u0107 Z., Mateji\u0107 J., Sharifi-Rad M., Anil Kumar N.V., Martins N., Sharifi-Rad J. The therapeutic potential of curcumin: A review of clinical trials. Eur. J. Med. Chem. 2019;163:527\u2013545. doi: 10.1016/j.ejmech.2018.12.016.", "ArticleIdList": ["10.1016/j.ejmech.2018.12.016", "30553144"]}, {"Citation": "Liu Z., Ying Y. The inhibitory effect of curcumin on virus-induced cytokine storm and its potential use in the associated severe pneumonia. Front. Cell Dev. Biol. 2020;8:479. doi: 10.3389/fcell.2020.00479.", "ArticleIdList": ["10.3389/fcell.2020.00479", "PMC7303286", "32596244"]}, {"Citation": "Pawar K.S., Mastud R.N., Pawar S.K., Pawar S.S., Bhoite R.R., Bhoite R.R., Kulkarni M.V., Deshpande A.R. Oral curcumin with piperine as adjuvant therapy for the treatment of COVID-19: A randomized clinical trial. Front. Pharmacol. 2021;12:669362. doi: 10.3389/fphar.2021.669362.", "ArticleIdList": ["10.3389/fphar.2021.669362", "PMC8193734", "34122090"]}, {"Citation": "Shou S., Liu M., Yang Y., Kang N., Song Y., Tan D., Liu N., Wang F., Liu J., Xie Y. Animal models for COVID-19: Hamsters, mouse, ferret, mink, tree shrew, and non-human primates. Front. Microbiol. 2021;12:626553. doi: 10.3389/fmicb.2021.626553.", "ArticleIdList": ["10.3389/fmicb.2021.626553", "PMC8438334", "34531831"]}, {"Citation": "Deng W., Xu Y., Kong Q., Xue J., Yu P., Liu J., Lv Q., Li F., Wei Q., Bao L. Therapeutic efficacy of Pudilan Xiaoyan Oral Liquid (PDL) for COVID-19 in vitro and in vivo. Signal. Transduct. Target. Ther. 2020;5:66. doi: 10.1038/s41392-020-0176-0.", "ArticleIdList": ["10.1038/s41392-020-0176-0", "PMC7205908", "32385228"]}, {"Citation": "Tessier C.M., Kokkinos A., Mingrone G., Koliaki C., Zierath J.R., Mantzoros C.S. COVID-19 editorial: Mechanistic links and therapeutic challenges for metabolic diseases one year into the COVID-19 pandemic. Metabolism. 2021;119:154769. doi: 10.1016/j.metabol.2021.154769.", "ArticleIdList": ["10.1016/j.metabol.2021.154769", "PMC7997260", "33775648"]}, {"Citation": "Chia W.Y., Kok H., Chew K.W., Low S.S., Show P.L. Can algae contribute to the war with COVID-19? Bioengineered. 2021;12:1226\u20131237. doi: 10.1080/21655979.2021.1910432.", "ArticleIdList": ["10.1080/21655979.2021.1910432", "PMC8806238", "33858291"]}, {"Citation": "Khazeei Tabari M.A., Iranpanah A., Bahramsoltani R., Rahimi R. Flavonoids as promising antiviral agents against SARS-CoV-2 infection: A mechanistic review. Molecules. 2021;26:3900. doi: 10.3390/molecules26133900.", "ArticleIdList": ["10.3390/molecules26133900", "PMC8271800", "34202374"]}, {"Citation": "Alam S., Sarker M.M.R., Afrin S., Richi F.T., Zhao C., Zhou J.-R., Mohamed I.N. Traditional herbal medicines, bioactive metabolites, and plant products against COVID-19: Update on clinical trials and mechanism of actions. Front. Pharmacol. 2021;12:671498. doi: 10.3389/fphar.2021.671498.", "ArticleIdList": ["10.3389/fphar.2021.671498", "PMC8194295", "34122096"]}, {"Citation": "He Y.-Q., Zhou C.-C., Yu L.-Y., Wang L., Deng J., Tao Y.-L., Zhang F., Chen W.-S. Natural product derived phytochemicals in managing acute lung injury by multiple mechanisms. Pharmacol. Res. 2021;163:105224. doi: 10.1016/j.phrs.2020.105224.", "ArticleIdList": ["10.1016/j.phrs.2020.105224", "PMC7522693", "33007416"]}, {"Citation": "Oliviero F., Scanu A., Zamudio-Cuevas Y., Punzi L., Spinella P. Anti-inflammatory effects of polyphenols in arthritis. J. Sci. Food Agric. 2018;98:1653\u20131659. doi: 10.1002/jsfa.8664.", "ArticleIdList": ["10.1002/jsfa.8664", "28886220"]}, {"Citation": "Pandey K.B., Rizvi S.I. Plant polyphenols as dietary antioxidants in human health and disease. Oxid. Med. Cell. Longev. 2009;2:270\u2013278. doi: 10.4161/oxim.2.5.9498.", "ArticleIdList": ["10.4161/oxim.2.5.9498", "PMC2835915", "20716914"]}, {"Citation": "Di Pierro F., Derosa G., Maffioli P., Bertuccioli A., Togni S., Riva A., Allegrini P., Khan A., Khan S., Khan B.A., et al. Possible therapeutic effects of adjuvant quercetin supplementation against early-stage COVID-19 infection: A prospective, randomized, controlled, and open-label study. Int. J. Gen. Med. 2021;14:2359\u20132366. doi: 10.2147/IJGM.S318720.", "ArticleIdList": ["10.2147/IJGM.S318720", "PMC8197660", "34135619"]}, {"Citation": "Walle T., Hsieh F., DeLegge M.H., Oatis J.E., Walle U.K. High absorption but very low bioavailability of oral resveratrol in humans. Drug Metab. Dispos. 2004;32:1377\u20131382. doi: 10.1124/dmd.104.000885.", "ArticleIdList": ["10.1124/dmd.104.000885", "15333514"]}, {"Citation": "Hamada H., Hamada H., Shimoda K., Kuboki A., Iwaki T., Kiriake Y., Ishihara K. Resveratrol oligosaccharides (gluco-oligosaccharides) effectively inhibit SARS-CoV-2 infection: Glycoside (polysaccharide) approach for treatment of COVID-19. Nat. Prod. Commun. 2021;16:1934578X211012903. doi: 10.1177/1934578X211012903.", "ArticleIdList": ["10.1177/1934578X211012903"]}, {"Citation": "Noor N., Gani A., Gani A., Shah A., Ashraf U.Z. Exploitation of polyphenols and proteins using nanoencapsulation for anti-viral and brain boosting properties\u2014Evoking a synergistic strategy to combat COVID-19 pandemic. Int. J. Biol. Macromol. 2021;180:375\u2013384. doi: 10.1016/j.ijbiomac.2021.03.028.", "ArticleIdList": ["10.1016/j.ijbiomac.2021.03.028", "PMC7946821", "33716131"]}, {"Citation": "Rossi G.A., Sacco O., Capizzi A., Mastromarino P. Can Resveratrol-inhaled formulations be considered potential adjunct treatments for COVID-19? Front. Immunol. 2021;12:670955. doi: 10.3389/fimmu.2021.670955.", "ArticleIdList": ["10.3389/fimmu.2021.670955", "PMC8172170", "34093569"]}, {"Citation": "Reich H.N., Oudit G.Y., Penninger J.M., Scholey J.W., Herzenberg A.M. Decreased glomerular and tubular expression of ACE2 in patients with type 2 diabetes and kidney disease. Kidney Int. 2008;74:1610\u20131616. doi: 10.1038/ki.2008.497.", "ArticleIdList": ["10.1038/ki.2008.497", "19034303"]}, {"Citation": "Kobayashi Y., Suzuki M., Satsu H., Arai S., Hara Y., Suzuki K., Miyamoto Y., Shimizu M. Green tea polyphenols inhibit the sodium-dependent glucose transporter of intestinal epithelial cells by a competitive mechanism. J. Agric. Food Chem. 2000;48:5618\u20135623. doi: 10.1021/jf0006832.", "ArticleIdList": ["10.1021/jf0006832", "11087528"]}, {"Citation": "Alqarni M.H., Foudah A.I., Muharram M.M., Labrou N.E. The Pleiotropic Function of Human Sirtuins as Modulators of Metabolic Pathways and Viral Infections. Cells. 2021;10:460. doi: 10.3390/cells10020460.", "ArticleIdList": ["10.3390/cells10020460", "PMC7927137", "33669990"]}, {"Citation": "Chen W.-P., Chi T.-C., Chuang L.-M., Su M.-J. Resveratrol enhances insulin secretion by blocking KATP and KV channels of beta cells. Eur. J. Pharmacol. 2007;568:269\u2013277. doi: 10.1016/j.ejphar.2007.04.062.", "ArticleIdList": ["10.1016/j.ejphar.2007.04.062", "17573071"]}, {"Citation": "Barone E., Calabrese V., Mancuso C. Ferulic acid and its therapeutic potential as a hormetin for age-related diseases. Biogerontology. 2009;10:97\u2013108. doi: 10.1007/s10522-008-9160-8.", "ArticleIdList": ["10.1007/s10522-008-9160-8", "18651237"]}, {"Citation": "Rizvi S.I., Mishra N. Anti-oxidant effect of quercetin on type 2 diabetic erythrocytes. J. Food Biochem. 2009;33:404\u2013415. doi: 10.1111/j.1745-4514.2009.00228.x.", "ArticleIdList": ["10.1111/j.1745-4514.2009.00228.x"]}, {"Citation": "Semiz S., Serdarevic F. Prevention and management of type 2 diabetes and metabolic syndrome in the time of COVID-19: Should we add a cup of coffee? Front. Nutr. 2020;7:581680. doi: 10.3389/fnut.2020.581680.", "ArticleIdList": ["10.3389/fnut.2020.581680", "PMC7573071", "33123550"]}, {"Citation": "Garc\u00eda-Lafuente A., Guillam\u00f3n E., Villares A., Rostagno M.A., Mart\u00ednez J.A. Flavonoids as anti-inflammatory agents: Implications in cancer and cardiovascular disease. Inflamm. Res. 2009;58:537\u2013552. doi: 10.1007/s00011-009-0037-3.", "ArticleIdList": ["10.1007/s00011-009-0037-3", "19381780"]}, {"Citation": "Pirola L., Fr\u00f6jd\u00f6 S. Resveratrol: One molecule, many targets. IUBMB Life. 2008;60:323\u2013332. doi: 10.1002/iub.47.", "ArticleIdList": ["10.1002/iub.47", "18421779"]}, {"Citation": "Fontelo P., Bastola M.M., Zheng Z., Baik S.H. A review of thromboembolic events in hospitalized COVID-19 patients. Thromb. J. 2021;19:47. doi: 10.1186/s12959-021-00298-3.", "ArticleIdList": ["10.1186/s12959-021-00298-3", "PMC8240420", "34187490"]}, {"Citation": "G\u00f3mez-Mesa J.E., Galindo-Coral S., Montes M.C., Mu\u00f1oz Martin A.J. Thrombosis and coagulopathy in COVID-19. Curr. Probl. Cardiol. 2021;46:100742. doi: 10.1016/j.cpcardiol.2020.100742.", "ArticleIdList": ["10.1016/j.cpcardiol.2020.100742", "PMC7605852", "33243440"]}, {"Citation": "Leentjens J., van Haaps T.F., Wessels P.F., Schutgens R.E.G., Middeldorp S. COVID-19-associated coagulopathy and antithrombotic agents\u2014lessons after 1 year. Lancet Haematol. 2021;8:e524\u2013e533. doi: 10.1016/S2352-3026(21)00105-8.", "ArticleIdList": ["10.1016/S2352-3026(21)00105-8", "PMC8078884", "33930350"]}, {"Citation": "Nignpense B.E., Chinkwo K.A., Blanchard C.L., Santhakumar A.B. Polyphenols: Modulators of platelet function and platelet microparticle generation? Int. J. Mol. Sci. 2019;21:146. doi: 10.3390/ijms21010146.", "ArticleIdList": ["10.3390/ijms21010146", "PMC6981839", "31878290"]}, {"Citation": "Boji\u0107 M., Antoli\u0107 A., Tomi\u010di\u0107 M., Debeljak \u017d., Male\u0161 \u017d. Propolis ethanolic extracts reduce adenosine diphosphate induced platelet aggregation determined on whole blood. Nutr. J. 2018;17:52. doi: 10.1186/s12937-018-0361-y.", "ArticleIdList": ["10.1186/s12937-018-0361-y", "PMC5952650", "29759064"]}, {"Citation": "Liu L., Ma H., Yang N., Tang Y., Guo J., Tao W., Duan J. A Series of natural flavonoids as thrombin inhibitors: Structure-activity relationships. Thromb. Res. 2010;126:e365\u2013e378. doi: 10.1016/j.thromres.2010.08.006.", "ArticleIdList": ["10.1016/j.thromres.2010.08.006", "20828797"]}, {"Citation": "Bijak M., Ziewiecki R., Saluk J., Ponczek M., Pawlaczyk I., Krotkiewski H., Wachowicz B., Nowak P. Thrombin inhibitory activity of some polyphenolic compounds. Med. Chem. Res. 2014;23:2324\u20132337. doi: 10.1007/s00044-013-0829-4.", "ArticleIdList": ["10.1007/s00044-013-0829-4", "PMC3939009", "24610996"]}, {"Citation": "Hu H., Zhang X., Wang Y., Chen S. Honokiol inhibits arterial thrombosis through endothelial cell protection and stimulation of prostacyclin. Acta Pharmacol. Sin. 2005;26:1063\u20131068. doi: 10.1111/j.1745-7254.2005.00164.x.", "ArticleIdList": ["10.1111/j.1745-7254.2005.00164.x", "16115372"]}, {"Citation": "Ricordi C., Pacifici F., Lanzoni G., Palamara A.T., Garaci E., Della-Morte D. Dietary and protective factors to halt or mitigate progression of autoimmunity, COVID-19 and its associated metabolic diseases. Int. J. Mol. Sci. 2021;22:3134. doi: 10.3390/ijms22063134.", "ArticleIdList": ["10.3390/ijms22063134", "PMC8003583", "33808574"]}, {"Citation": "Kempuraj D., Thangavel R., Kempuraj D.D., Ahmed M.E., Selvakumar G.P., Raikwar S.P., Zaheer S.A., Iyer S.S., Govindarajan R., Chandrasekaran P.N., et al. Neuroprotective effects of flavone luteolin in neuroinflammation and neurotrauma. BioFactors. 2021;47:190\u2013197. doi: 10.1002/biof.1687.", "ArticleIdList": ["10.1002/biof.1687", "33098588"]}, {"Citation": "Tabak C., Arts I.C.W., Smit H.A., Heederik D., Kromhout D. Chronic obstructive pulmonary disease and intake of catechins, flavonols, and flavones. Am. J. Respir. Crit. Care Med. 2001;164:61\u201364. doi: 10.1164/ajrccm.164.1.2010025.", "ArticleIdList": ["10.1164/ajrccm.164.1.2010025", "11435239"]}, {"Citation": "Franceschini E., Cozzi-Lepri A., Santoro A., Bacca E., Lancellotti G., Menozzi M., Gennari W., Meschiari M., Bedini A., Orlando G., et al. Herpes simplex virus re-activation in patients with SARS-CoV-2 pneumonia: A prospective, observational study. Microorganisms. 2021;9:1896. doi: 10.3390/microorganisms9091896.", "ArticleIdList": ["10.3390/microorganisms9091896", "PMC8465957", "34576791"]}, {"Citation": "Treml J., Gazdov\u00e1 M., \u0160mejkal K., \u0160udomov\u00e1 M., Kubatka P., Hassan S.T.S. Natural products-derived chemicals: Breaking barriers to novel anti-HSV drug development. Viruses. 2020;12:154. doi: 10.3390/v12020154.", "ArticleIdList": ["10.3390/v12020154", "PMC7077281", "32013134"]}, {"Citation": "Zhou F., Yu T., Du R., Fan G., Liu Y., Liu Z., Xiang J., Wang Y., Song B., Gu X., et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study. Lancet. 2020;395:1054\u20131062. doi: 10.1016/S0140-6736(20)30566-3.", "ArticleIdList": ["10.1016/S0140-6736(20)30566-3", "PMC7270627", "32171076"]}, {"Citation": "Kawabata K., Yoshioka Y., Terao J. Role of Intestinal Microbiota in the Bioavailability and Physiological Functions of Dietary Polyphenols. Molecules. 2019;24:370. doi: 10.3390/molecules24020370.", "ArticleIdList": ["10.3390/molecules24020370", "PMC6359708", "30669635"]}, {"Citation": "Greene M.W., Roberts A.P., Frug\u00e9 A.D. Negative Association between mediterranean diet adherence and COVID-19 cases and related deaths in spain and 23 oecd countries: An ecological study. Front. Nutr. 2021;8:591964. doi: 10.3389/fnut.2021.591964.", "ArticleIdList": ["10.3389/fnut.2021.591964", "PMC7973012", "33748170"]}, {"Citation": "Ngwa W., Kumar R., Thompson D., Lyerly W., Moore R., Reid T.-E., Lowe H., Toyang N. Potential of flavonoid-inspired phytomedicines against COVID-19. Molecules. 2020;25:2707. doi: 10.3390/molecules25112707.", "ArticleIdList": ["10.3390/molecules25112707", "PMC7321405", "32545268"]}, {"Citation": "Hano C., Tungmunnithum D. Plant polyphenols, more than just simple natural antioxidants: Oxidative stress, aging and age-related diseases. Medicines. 2020;7:26. doi: 10.3390/medicines7050026.", "ArticleIdList": ["10.3390/medicines7050026", "PMC7281114", "32397520"]}, {"Citation": "Zhang L., McClements D.J., Wei Z., Wang G., Liu X. Delivery of synergistic polyphenol combinations using biopolymer-based systems: Advances in physicochemical properties, stability and bioavailability. Crit. Rev. Food Sci. Nutr. 2020;60:2083\u20132097. doi: 10.1080/10408398.2019.1630358.", "ArticleIdList": ["10.1080/10408398.2019.1630358", "31257900"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "10", "Day": "11"}, {"Year": "2021", "Month": "11", "Day": "8"}, {"Year": "2021", "Month": "11", "Day": "9"}, {"Year": "2021", "Month": "11", "Day": "27", "Hour": "1", "Minute": "11"}, {"Year": "2021", "Month": "11", "Day": "28", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "12", "Day": "15", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "11", "Day": "17"}], "PublicationStatus": "epublish", "ArticleIdList": ["34830267", "PMC8625847", "10.3390/ijms222212385", "ijms222212385"]}}], "PubmedBookArticle": []}